Results found (477)
March 19, 2012
New weapon against pancreatic and prostate cancer

An Israeli pharma company is testing an advanced compound that blocks a tumor's blood supply. Used with standard chemo, it obliterates the growth.

March 12, 2012
Israel’s superbug detective kit

A new technology -- developed by a 91-year-old scientist at the Hebrew University in Jerusalem -- is putting Israel way out front in the worldwide fight against antibiotic-resistant bacteria.

March 4, 2012
Yissum Signs Licensing Agreement with Dow AgroFresh for a Novel...

Yissum, the research and development company of the Hebrew University of Jerusalem, North Carolina State University, Raleigh , N.C., and Dow AgroFresh, a business unit of Rohm and Haas Company, a wholly owned subsidiary of The Dow Chemical...

February 27, 2012
BioConnections, Yissum to commercialize kits that detect MDR and XDR infections

Yissum, the research and development company of the Hebrew University of Jerusalem, had signed a licensing agreement with BioConnections, a UK based microbiology company, for the commercialization of kits that enables immediate detection of all...

February 14, 2012
Tiltan begins Phase II pancreatic cancer trial

Tiltan Pharma Ltd has begun a Phase II clinical trial of its TL-118 drug for the treatment of pancreatic cancer. The trial will include 80 patients at three Israeli hospitals, and will take about a year.

January 30, 2012
IMMUNE Pharmaceuticals Granted US$1 Million (NIS 3.8M) by the Office of the...

ERZLIYA, Israel and NEW YORK, Jan 30, 2012 (GlobeNewswire via COMTEX) -- IMMUNE Pharmaceuticals, an emerging leader in the development of monoclonal antibody based therapeutics for the treatment of inflammatory diseases and cancer, today...

January 18, 2012
Israeli Team Produces Anti-Malaria Drug From Tobacco Plants

Israeli scientists, led by Hebrew University Professor, Alexander Vainstein, are using genetically modified tobacco to produce the anti-malaria drug artemisinin.

January 10, 2012
“Do I fit?” a system for assessing the degree to which a person fits to...

"Do I Fit?" System was developed by Kivunim team headed by Prof. Itamar Gati, is aimed at assessing the degree to an individual’s career-related preferences fit the core characteristics of an occupation he or she considers. The system currently...

December 22, 2011
Bio-filter blasts nitrates out of the water

Nitrates in drinking water pose serious health problems, but a new low-tech solution from Israel is coming to the rescue.

December 19, 2011
Yissum Presents: Tobacco plant can produce anti-malaria drug

Hebrew University researchers used plan to produce an effective anti-malaria drug; combating malaria is one of the eight Millennium Development Goals.


December 19, 2011
Therapeutics co AtoxBio raises $3.25m

Atox Bio will be included as one of the portfolio companies of Integra Holdings, a holding company formed by Yissum, the technology transfer company of the Hebrew University of Jerusalem.

December 11, 2011
Here Come the NanoMABs - A new monoclonal antibody-based drug

A new monoclonal antibody-based drug development company brings a fresh technological approach and ambitious business model to the Israeli biotech scene.